Open Access Policy | Advanced Drug Sciences

About Journal

Advanced Drug Sciences (ADS) is an international, peer-reviewed Gold Open Access journal published by Universitas Muhammadiyah Surakarta (UMS), Indonesia. The journal is dedicated to advancing the science of drug discovery, development, and therapeutic application by publishing high-quality, original, and interdisciplinary research.

ADS provides a multidisciplinary platform that integrates pharmaceutical, biomedical, and clinical sciences, with a strong emphasis on mechanistic understanding, technological innovation, and translational relevance.

The journal aims to bridge the continuum from molecular design and formulation to clinical outcomes and population-level health impact.

The journal operates under a Gold Open Access model, ensuring that all accepted articles are immediately and permanently accessible without subscription barriers. Articles are published under a continuous publication model to enable rapid dissemination of scientific findings.

ADS welcomes contributions that advance both fundamental knowledge and practical applications in drug sciences, including, but not limited to, drug discovery and medicinal chemistry, pharmaceutics and advanced drug delivery, pharmacology and pharmacokinetics, biopharmaceuticals and biotechnology-derived therapeutics, and clinical and translational research.

Through rigorous peer review and adherence to internationally recognized ethical standards, ADS is committed to publishing scientifically robust research that contributes to innovation in drug development and the improvement of global healthcare outcomes.

Advanced Drug Sciences (ADS) is a fully open access journal. All articles are made freely and permanently available online immediately upon publication, without subscription or access barriers.

This policy is consistent with the principles of the Budapest Open Access Initiative (BOAI) , which advocates for the free availability of research literature on the public internet, permitting users to read, download, copy, distribute, print, search, or link to the full texts of articles without financial, legal, or technical barriers.

Access and Reuse

Users are permitted to:

Read and download the full text of all articles
Copy and redistribute the material in any medium or format
Adapt, remix, transform, and build upon the material
Use the content for any lawful purpose, including commercial use

All reuse must comply with the terms of the CC BY 4.0 license, including proper attribution to the original authors and source.

Author Rights

Authors retain copyright of their work and grant ADS the right to publish and disseminate the article as the original publisher. Authors may share and reuse their published work without restriction, provided that proper attribution is maintained.

Self-Archiving Policy

The journal supports open dissemination of research and allows authors to deposit and share their manuscript at any stage of the publication process.

Preprint: Authors may share the submitted version prior to peer review.
Accepted Manuscript: Authors may share the peer-reviewed and accepted version.
Version of Record: Authors may share the final published version.

Deposited versions should include a proper citation and, where available, a link to the final published article in Advanced Drug Sciences.

This policy is compatible with international repository standards such as SHERPA/RoMEO.